Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
45 participants
OBSERVATIONAL
2022-06-20
2022-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LGMDs Patients
Patients with a genetically confirmed diagnosis of a LGMD subtype 2A, 2B, or 2I
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥14 years of age at the timing of consent (if age 14 - 17, consent from the parent/ legal guardian is also needed)
* Able to read, speak, and understand English
* Residing in the USA
* Willing and able to complete an electronic survey, which includes questions about personal characteristics and medical history as well as review of tasks
* Willing and able to discuss their experiences as a person living with an LGMD in a group setting
* Willing and able to complete 2 rounds of video capture following instructions in the LGVA Video Capture Manual in a 30-day period
* Willing and able to complete an exit interview to discuss their experiences capturing and recording videos with the LGVA Video Capture Manual
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coalition to Cure Calpain 3 (C3)
UNKNOWN
Jain Foundation
OTHER
The Emmes Company, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lauren Carroll
Role: STUDY_DIRECTOR
Casimir
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Casimir
Kingston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAS-CAS008-01
Identifier Type: -
Identifier Source: org_study_id